MYM Nutraceuticals, Inc. (OTC: MYMMF) Rob Gietl, CEO Interview. Medicinal cannabis company projects “$3 billion revenues in 2020”.

 

 

 

 

MYM Nutraceuticals, Inc. (CSE: MYM) (OTC: MYMMF) CEO Interview with Rob Gietl, discussing progress toward the company's goal of becoming a vertically integrated player in the medicinal cannabis space, with a multi-national footprint. Rob addresses the recent CDN$50 million shelf offering, cannabis growing facilities coming online, starting in Q1 2019, and his objective of "$3 billion revenues in 2020".

 

 

Investor Presentation

 

  . . .

This content is available to members only.

If you are an existing member, please LOGIN

Note a member? Sign up for a FREE account ($89 per month value), and get immediate access. Free offer expires March 29, 2019.

Register New Account

Free Membership

.

Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2
subscribe@wallstreetreporter.com.